Observe Medical ASA (OSL:OBSRV)
Norway · Delayed Price · Currency is NOK 0.9740
-0.0260 (-2.60%)
At close: Aug 4, 2026
Observe Medical ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 11.5 | 1.98 | 13.68 | 13.64 | 2.86 |
Cash & Short-Term Investments | 11.5 | 1.98 | 13.68 | 13.64 | 2.86 |
Cash Growth | 481.40% | -85.54% | 0.26% | 376.29% | -84.88% |
Accounts Receivable | 0 | 2.76 | 3.12 | 4.73 | 1.35 |
Other Receivables | 2.37 | 1.66 | 3.57 | 2.44 | 3.93 |
Total Trade Receivables | 2.37 | 4.42 | 6.69 | 7.17 | 5.28 |
Inventory | 7.48 | 5.33 | 6.89 | 8.12 | 7.01 |
Total Current Assets | 21.35 | 11.73 | 27.25 | 28.93 | 15.16 |
Net Property, Plant & Equipment | 0.06 | 0.2 | 1.96 | 4.15 | 1.38 |
Other Intangible Assets | 44.6 | 97.66 | 109.19 | 82.77 | 21.33 |
Goodwill | 35.16 | 33.07 | 35.21 | 99.96 | 33.87 |
Total Assets | 101.17 | 142.65 | 173.61 | 215.81 | 71.74 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 12.94 | 18.12 | 17.85 | 8.61 | 6.16 |
Accrued Expenses | 6.42 | 7.7 | 10.57 | 6.13 | 3.75 |
Short-Term Debt | - | - | - | - | 6.51 |
Current Portion of Long-Term Debt | 10.82 | 21.73 | 4.48 | 44.8 | 48.01 |
Current Portion of Leases | - | - | 0.66 | - | - |
Other Current Liabilities | 14.21 | 12.32 | 27.33 | 12.69 | 7.85 |
Total Current Liabilities | 44.39 | 59.87 | 60.88 | 72.23 | 72.28 |
Long-Term Debt | 19.92 | 61.64 | 50.79 | 0.95 | 0 |
Long-Term Leases | - | - | - | - | 0.55 |
Other Long-Term Liabilities | 6.9 | 0 | 21.07 | 4.33 | 13.03 |
Total Long-Term Liabilities | 26.82 | 61.64 | 71.86 | 5.28 | 13.58 |
Total Liabilities | 71.21 | 121.51 | 132.74 | 77.51 | 85.86 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 57.18 | 75.11 | 49.58 | 13.91 | 5.1 |
Additional Paid-in Capital | 4.4 | 302.7 | 289.77 | - | - |
Retained Earnings | -31.62 | -356.67 | -298.48 | 124.4 | -19.22 |
Shareholders' Equity | 29.96 | 21.14 | 40.87 | 138.31 | -14.12 |
Total Liabilities & Equity | 101.17 | 142.65 | 173.61 | 215.81 | 71.74 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 30.74 | 83.37 | 55.92 | 45.75 | 55.07 |
Net Cash (Debt) | -19.24 | -81.39 | -42.25 | -32.11 | -52.21 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.29 | -5.47 | -13.42 | -10.20 | -39.92 |
Book Value | 29.96 | 21.14 | 40.87 | 138.31 | -14.12 |
Book Value Per Share | 0.45 | 1.42 | 12.99 | 43.95 | -10.80 |
Tangible Book Value | -49.8 | -109.59 | -103.53 | -44.42 | -69.32 |
Tangible Book Value Per Share | -0.75 | -7.37 | -32.90 | -14.11 | -53.01 |